Evidence map›Paper›PMID 40888007›Full record

Trial reportBJOG : an international journal of obstetrics and gynaecology2026

Duration of Intrauterine Balloon Tamponade in Post-Partum Haemorrhage Management After Vaginal Delivery: A Secondary Cohort Analysis From the French TUB Trial.

Charles Garabedian, Charlotte Prats, Aurélien Seco, Catherine Deneux-Tharaux, Patrick Rozenberg, Paul Berveiller

Abstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in BJOG : an international journal of obstetrics and gynaecology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Charles GarabedianCHU Lille, Department of Obstetrics, Lille, France.
Charlotte PratsDepartment of Obstetrics and Gynecology, Centre Hospitalier Intercommunal de Poissy/Saint-Germain-en-Laye, Poissy, France.
Aurélien SecoUniversité Paris Cité, CRESS U1153, Obstetrical Perinatal and Pediatric Epidemiology (EPOPé) Research Team, INSERM, Paris, France.
Catherine Deneux-TharauxUniversité Paris Cité, CRESS U1153, Obstetrical Perinatal and Pediatric Epidemiology (EPOPé) Research Team, INSERM, Paris, France.ORCID https://orcid.org/0000-0002-6561-3321
Patrick RozenbergParis Saclay University, UVSQ, Inserm, Team U1018, Clinical Epidemiology, CESP, Montigny-le-Bretonneux, France.
Paul BerveillerDepartment of Obstetrics and Gynecology, Centre Hospitalier Intercommunal de Poissy/Saint-Germain-en-Laye, Poissy, France.ORCID https://orcid.org/0000-0002-7814-6945

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo compare the rates of bleeding recurrence and other post-partum haemorrhage (PPH)-related clinical outcomes in women with PPH initially controlled by intrauterine balloon tamponade (IUBT) according to its duration.

designExploratory cohort study from a randomised trial.

settingEighteen hospitals in France. POPULATION: All women included in the randomised trial and managed with IUBT. Those whose balloon was removed within the first 2 h of placement because of spontaneous expulsion and those who underwent invasive procedures before the planned IUBT removal were excluded.

methodsThe first quartile of the distribution of the IUBT duration was 6.9 h, and we divided the population into two groups according to the duration: ≤ 7 h vs.> 7 h. To control for confounding factors, we used a propensity score adjustment approach.

main outcome measuresNeed for an invasive procedure, rate of recurrence of bleeding after removal of the IUBT, and mean quantified peri-partum blood loss.

resultsTotally, 199 women were included. No invasive procedures were performed, and there was no recurrence of bleeding in either group. There were no significant differences in mean (±SD) quantified total blood loss (1126 ± 383 mL vs. 1240 ± 505 mL, p = 0.1) or the need for transfusion (9 [18%] vs. 40 [27%], p = 0.2) between groups, even after adjustment.

conclusionsA shorter IUBT duration (7 h) is not associated with unfavourable PPH outcomes and may therefore be a reasonable option if ongoing haemorrhage has abated. However, these findings should be interpreted with caution due to the imbalance in clinical indication between groups.

Indexed as

Postpartum HemorrhageUterine Balloon TamponadeAdultCohort StudiesDelivery, ObstetricFemaleFranceHumansPregnancyRecurrenceTime FactorsTreatment Outcomeendometritisintrauterine ballon tamponadepost‐partum haemorrhagesulprostoneuterotonic

Identifiers

PMID40888007
PMCPMC12676195

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.